Nanyang Tianhua Biotechnology Group Co., Ltd. is a large-scale high-tech pharmaceutical company integrating product R & D, production, and sales. There are more than ten branches, including 3 GMP factories: Nanyang Tianhua Pharmaceutical Co., Ltd., Nanyang Libang Pharmaceutical Co., Ltd. and Henan Quanyu Pharmaceutical Co., Ltd.. The group's business involves many fields such as human-used API, medicine, Chinese traditional medicines, veterinary API and preparations.
At present, human-used API,veterinary API and preparations have exported to many countries and regions such as Japan,Korea,Taiwan,Southeast Asia, South America,Europe and Africa.
The main APIs are as belows:Almitrine bismesylate, Bethanechol chloride, Chlorzoxazone,Tiopronin, Sulfamonomethoxine (Sodium), sulfachloropyrazine sodium,sulfadiazine(sodium),Sodium camphorsulphonate, Diminazene Aceturate, Probenecid,Urotropine,Mequindox,Silver sulfadiazine , Zinc sulfadiazine,Sulfadiazine,Quinocetone,Urotropine,Nicarbazine, 25%Nicarbazine premix,and so on.
We always insist on win-win cooperation concept.With high quality, reasonable price,on-time delivery and reliable service,we have won the good reputation in the pharmaceutical industry.Sincerely welcome you to negotiate cooperation.We will do our best for you.
more >
Year of Establishment:
1996
Total Assets(USD):
500,000 to 99,999,999
Total Number of Staff:
500-1000
Main Competitive Advantages:
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages:
High quality
Strict management
Patents and Copyrights:
Business Type:
Manufacturer
R&D capacity:
Own Brand
Annual Turnover(USD):
500,000 to 99,999,999
Main Sales Markets:
Central/South America,Western Europe,Eastern Europe,Asia,Middle East,Africa
Other Competitive Advantages:
High quality
Strict management
Patents and Copyrights: